Analisis Keuangan Saham TFFP - TFF Pharmaceuticals, Inc. (NasdaqCM) Stock

TFF Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US87241J1043
HINDI NA ACTIVE ANG SIMBONG ITO

Gambaran Umum
Ang TFF Pharmaceuticals, Inc., na nakabase sa United States, ay nagpapatakbo sa loob ng biopharmaceutical sector na pangunahing nakatuon sa pagbuo at pagkomersyal ng mga produkto ng gamot batay sa pagmamay-ari nitong Thin Film Freezing (TFF) na teknolohiya. Ang teknolohiyang ito ay naglalagay ng iba't ibang sangkap ng gamot sa mga nalalanghap na dry powder formulations, na naglalayong mapabuti ang solubility at pagsipsip ng mga gamot na hindi nalulusaw sa tubig at magbigay ng alternatibo sa mga tradisyonal na paraan ng paghahatid. Kabilang sa mga pangunahing proyekto ang pagsulong ng mga paggamot para sa mga kondisyon tulad ng mga impeksyon sa baga at mga sakit sa baga, kabilang ang isang pormulasyon ng Voriconazole na nilalayon upang gamutin ang invasive pulmonary aspergillosis. Sinasaliksik din ng kumpanya ang mga pakikipagsosyo upang magamit ang platform ng TFF nito sa pagpapahusay ng bisa at paghahatid ng mga kasalukuyang therapy sa gamot.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
Metrik Penilaian: PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
Efektivitas Manajemen
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
Gross Margins
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)1733413
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations
Other Listings
DE:0K30
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista